Key differences explained Mar 23, 2026 Mar 23, 2026 Is Toujeo a GLP-1
Kryczek, I
The current medical consensus, supported by the EMA's 2013 review and subsequent updates, is that whilst a small increased risk cannot be entirely excluded, the overall evidence does not establish a definitive causal link between GLP-1 agonist use and pancreatitis
The study suggested that while the absolute risk remained relatively low, the risk was nonetheless significant enough to warrant consideration, especially in individuals with a history of gallbladder disease
Tamborlane WV, Barrientos-Perez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, et al
Overall, this shows the safety of liraglutide in combination with LAGB